In this video from the virtual American Society of Retina Specialists meeting, Caesar Luo, MD, discusses the progression of retinal disease in eyes of patients lost to follow-up for at least 6 months.
The patients with the Iluvien fluocinolone acetonide implant (Alimera Sciences) showed less progression to severe disease than patients treated with anti-VEGF therapy.
Uncategorized